| The Effects of the Electro, Heat and Cold -Therapy During Physiotherapy Treatment in Osteoarthritis(OA) of KNEE (NCT01112319) | Meir Medical Center | 2010-03-01 |
| To Test Bioequivalence Between Two Formulations of Paracetamol/Phenylephrine (NCT01112462) | McNeil AB | 2010-03-01 |
| Sym004 in Patients With Advanced Solid Tumors (NCT01117428) | Symphogen A/S | 2010-03-01 |
| Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults (NCT01162590) | GlaxoSmithKline | 2010-03-01 |
| Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma (NCT00979862) | National Cancer Institute (NCI) | 2010-03-01 |
| Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer (NCT01088347) | University Medical Center Groningen | 2010-03-01 |
| Aldosterone and the Metabolic Syndrome (NCT01103245) | Vanderbilt University Medical Center | 2010-03-01 |
| NAC as a Potential Treatment for Methamphetamine Dependence (NCT01063205) | Baylor College of Medicine | 2010-03-01 |
| Pedunculo-Pontin Nucleus (PPN) - Deep Brain Stimulation (DBS) in Gait and Balance Disturbance in Parkinson's Disease (PPN-GAB-PARK Study) (NCT00821743) | Centre Hospitalier Universitaire de Nice | 2010-03-01 |
| A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer (NCT01051479) | Wake Forest University Health Sciences | 2010-03-01 |
| Multiple Dose Safety Study of SRX246 Capsules in Healthy Volunteers (NCT01088932) | Azevan Pharmaceuticals | 2010-03-01 |
| Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers (NCT01087749) | University of California, San Francisco | 2010-03-01 |
| The Effect of Crystalloids and Colloids on Visceral Blood Flow (NCT01087853) | University of Nottingham | 2010-03-01 |
| Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions (NCT01209156) | Institute for Neurodegenerative Disorders | 2010-03-01 |
| A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese Subjects (NCT01096563) | AstraZeneca | 2010-03-01 |
| Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer (NCT01077453) | National Cancer Institute (NCI) | 2010-03-01 |
| Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors (NCT01118611) | Cancer Research UK | 2010-03-01 |
| Effect of External Heat on a Transdermal Granisetron Patch in Pharmacokinetics (PK) of Healthy Subjects (NCT01073696) | Kyowa Kirin Co., Ltd. | 2010-03-01 |
| A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers (NCT01115985) | Astellas Pharma Inc | 2010-03-01 |
| Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck (NCT01116336) | Emory University | 2010-03-01 |
| Effects of Diacetylmorphine (DAM) on Brain Function and Stress Response (NCT01174927) | University Hospital, Basel, Switzerland | 2010-03-01 |
| Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis (NCT01082653) | TCA Cellular Therapy | 2010-03-01 |
| TTP607 in Refractory Solid Malignancies (NCT00939172) | M.D. Anderson Cancer Center | 2010-03-01 |
| Seizure Advisory System Feasibility Study (NCT01043406) | NeuroVista Corporation | 2010-03-01 |
| Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ® (NCT01086982) | Azidus Brasil | 2010-03-01 |
| First in Man Study of Safety, Tolerability and PK Profile of RBP-7000 (NCT02765555) | Indivior Inc. | 2010-03-01 |
| A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product Testers (NCT01023100) | Pfizer | 2010-03-01 |
| A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients (NCT01253278) | Eli Lilly and Company | 2010-03-01 |
| Effect Of Maraviroc On The Pharmacokinetics Of Digoxin (NCT01056874) | ViiV Healthcare | 2010-03-01 |
| Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma (NCT01055496) | Pfizer | 2010-03-01 |
| Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis (NCT01024777) | Johns Hopkins University | 2010-03-01 |
| Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer (NCT01090011) | Boehringer Ingelheim | 2010-03-01 |
| Lapatinib With Sirolimus or Metformin (NCT01087983) | M.D. Anderson Cancer Center | 2010-03-01 |
| Safety of IFNa Kinoid in Systemic Lupus Erythematosus (NCT01058343) | Neovacs | 2010-03-01 |
| Multiple Dose Study of TRx0037 (NCT01253499) | TauRx Therapeutics Ltd | 2010-03-01 |
| A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors (NCT00951158) | Dartmouth-Hitchcock Medical Center | 2010-03-01 |
| Dichloroacetate (DCA) for the Treatment of Pulmonary Arterial Hypertension (NCT01083524) | University of Alberta | 2010-03-01 |
| A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy Volunteers (NCT01115972) | Astellas Pharma Inc | 2010-03-01 |
| Fluorescent Dyes for Lymph Node Mapping (NCT01095913) | M.D. Anderson Cancer Center | 2010-03-01 |
| Bevacizumab for Primary Pterygium Treatment (NCT01686529) | Instituto de Oftalmología Fundación Conde de Valenciana | 2010-03-01 |
| Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of 7.5, 10, 12.5 or 15 mg NRL001 in a 2 g Suppository for 14 Days (NCT01099670) | Norgine | 2010-03-01 |
| HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors (NCT00931931) | Timothy Cripe | 2010-03-01 |
| Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) (NCT01093911) | UCB Pharma | 2010-03-01 |
| A Study of the Safety and Tolerability of MEDI-551 in Scleroderma (NCT00946699) | MedImmune LLC | 2010-03-01 |
| Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma (NCT01134341) | Acrotech Biopharma Inc. | 2010-03-01 |
| Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects (NCT01068756) | AstraZeneca | 2010-03-01 |
| Galantamine Effects on Nicotine Responses in Smokers (NCT01417429) | Yale University | 2010-03-01 |
| Bioavailability Study Comparing 10 mg Amlodipine Besylate Orally Disintegrating Tablets (ODT) And 10 mg Amlodipine Besylate Capsules (NCT01177293) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-03-01 |
| Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease (NCT01107912) | Eli Lilly and Company | 2010-03-01 |
| Effect of Ridaforolimus on the Pharmacokinetics of Midazolam (Study MK-8669-044) (NCT01071304) | Merck Sharp & Dohme LLC | 2010-03-01 |
| Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit (NCT01087697) | Tengion | 2010-03-01 |
| A Study to Evaluate the Effect of Mipomersen on Cardiac Repolarization Conducted in Healthy Subjects (NCT01090661) | Kastle Therapeutics, LLC | 2010-03-01 |
| Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects (NCT01376063) | Kyntra Bio | 2010-03-01 |
| ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors (NCT01110486) | AbbVie (prior sponsor, Abbott) | 2010-03-01 |
| Targeting Oxidative Stress in Chronic Beryllium Disease (NCT01088243) | National Jewish Health | 2010-03-01 |
| Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant (NCT01106027) | Mayo Clinic | 2010-03-01 |
| Effect of Cabazitaxel on the QTc Interval in Cancer Patients (NCT01087021) | Sanofi | 2010-03-01 |
| A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration (NCT01158924) | DePuy Spine | 2010-03-01 |
| Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis (NCT01111279) | BioTech Tools S.A. | 2010-03-01 |
| Ascending Dose Study of the Safety and Tolerability of REGN727 (SAR236553) in Healthy Volunteers (NCT01074372) | Regeneron Pharmaceuticals | 2010-03-01 |
| Pharmacokinetics of AZD7295 Capsules (NCT01097408) | Arrow Therapeutics | 2010-03-01 |
| A Study on the Effect of Renal Function on the Pharmacakokinetics of RO5024048 (Parent of Prodrug RO5024048) Following Multiple Oral Dose Administration of RO5024048 (NCT01099904) | Hoffmann-La Roche | 2010-03-01 |
| TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions (NCT01052883) | Tibotec Pharmaceuticals, Ireland | 2010-03-01 |
| Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery. (NCT01094522) | Stanford University | 2010-03-01 |
| Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer (NCT01087554) | M.D. Anderson Cancer Center | 2010-03-01 |
| A Study to Assess the Efficacy and Safety of Fospropofol Disodium (NCT01271569) | West China Hospital | 2010-03-01 |
| Safety and Tolerability of STP206 in Healthy Adult Subjects (NCT00922324) | Leadiant Biosciences, Inc. | 2010-03-01 |
| GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers (NCT01118975) | University of Maryland, Baltimore | 2010-03-01 |
| Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection (NCT01067131) | Pevion Biotech Ltd | 2010-03-01 |
| Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer (NCT00963872) | Masonic Cancer Center, University of Minnesota | 2010-03-01 |
| Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants (NCT01068717) | AstraZeneca | 2010-03-01 |
| Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma (NCT01057225) | Mayo Clinic | 2010-03-01 |
| PiB PET Scanning in Speech and Language Based Dementias (NCT01623284) | Mayo Clinic | 2010-03-01 |
| Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid Tumors (NCT01021150) | Sanofi | 2010-03-01 |
| A Study of AdCh63 AMA1 Alone and With MVA AMA1 (NCT01095055) | University of Oxford | 2010-03-01 |
| Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors (NCT01055795) | Herbert Hurwitz | 2010-03-01 |
| Multiple Dose Japanese Bridging Study (NCT01057030) | Bristol-Myers Squibb | 2010-03-01 |
| A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C (NCT01087944) | Hoffmann-La Roche | 2010-03-01 |
| Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy Volunteers (NCT01135472) | City of Hope Medical Center | 2010-03-01 |
| The Use of Transcranial Direct Current Stimulation (tDCS) to Study Implicit Motor Learning on Patients With Brain Injury (NCT01127789) | National Taiwan University Hospital | 2010-03-01 |
| ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis (NCT01097668) | Apitope Technology (Bristol) Ltd. | 2010-03-01 |
| A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy (NCT01084174) | Johns Hopkins University | 2010-03-01 |
| Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial Pressure (NCT01089062) | Allergan | 2010-03-01 |
| TMC125HIV1083 - Swallowability of Uncoated 200 mg Etravirine Tablets in HIV-1 Infected Patients (NCT01090648) | Tibotec Pharmaceuticals, Ireland | 2010-03-01 |
| Study to Evaluate Safety, Tolerability, Maximum Tolerated Dose (MTD), Efficacy, and Pharmacokinetics (PKs) of CPI-613 Given Twice Weekly for Three Consecutive Weeks in Patients With Advanced Hematologic Malignancies (NCT01034475) | Wake Forest University Health Sciences | 2010-03-01 |
| Genotype Stratified Pharmacokinetic Study of Montelukast (NCT01086527) | Nemours Children's Clinic | 2010-03-01 |
| A Pilot Study of Shoulder Subluxation Treatment by Using the Self-Designed Surface Functional Electrical Stimulator (NCT01139034) | National Taiwan University Hospital | 2010-03-01 |
| A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function (NCT01278758) | Novartis Pharmaceuticals | 2010-03-01 |
| A Study of MEDI-575 in Patients With Advanced Solid Malignancies (NCT01102400) | AstraZeneca | 2010-03-01 |
| Lenalidomide and High-Dose Melphalan (NCT01079936) | M.D. Anderson Cancer Center | 2010-03-01 |
| Guanidinoacetic Acid (GAA) Administration in Physically Active Men and Women (NCT01133899) | Metropolitan University, Serbia | 2010-03-01 |
| Safety Study of NNZ-2566 in Healthy Female Subjects (NCT00961779) | Neuren Pharmaceuticals Limited | 2010-03-01 |
| The Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers (NCT02889822) | Guangzhou Yipinhong Pharmaceutical CO.,LTD | 2010-03-01 |
| Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer (NCT00905021) | Baylor Breast Care Center | 2010-03-01 |
| Baclofen and Hypoxia-induced Periodic Ventilation (NCT01095679) | Assistance Publique - Hôpitaux de Paris | 2010-03-01 |
| Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG (NCT03065036) | Ivantis, Inc. | 2010-03-01 |
| A Pharmacokinetic and Pharmacodynamic Study to Determine Blood Levels of JNJ-28431754 (Canagliflozin) in Patients With Type 2 Diabetes Mellitus (NCT01128985) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-03-01 |
| A Study of HM10560A in Healthy Male Subject (NCT01093742) | Hanmi Pharmaceutical Company Limited | 2010-03-01 |
| Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors (NCT01166035) | Medical University Innsbruck | 2010-03-01 |
| Effects of Raltegravir (Isentress®) on Lipid and Carbohydrate Metabolism and Mitochondrial Function in Healthy Volunteers (NCT00772720) | Hospital Clinic of Barcelona | 2010-03-01 |